The Case: Risa Mitigator, director of education for a state medical society, is frantic when her CEO tasks her with developing education regarding the “new REMS program.” Risa recalls hearing about the Food and Drug Administration’s Risk Evaluation and Management Strategies for extended-release and long-acting opioids. Prescription drug abuse is a crisis in her state. While eager to proceed, Risa is puzzled about how to plan continuing medical education activities in compliance with ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Risky REMS Remedy, you'll get exclusive access to a large archive of premium content.

Already registered? here.